CD274 and renal cell adenocarcinoma: In the group with a PD-L1-positive score≥1, the estimated ICER was 1,904,086.03 RMB/QALY, and in the group with a poor risk of International Metastatic RCC Database Consortium (IMDC), an additional 0.87 QALY was added, and the ICER was 1,514,440.51 RMB/QALY (see Table S3).